These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35747453)

  • 21. Cardiac implantable electronic device infection in patients with end-stage renal disease.
    Guha A; Maddox WR; Colombo R; Nahman NS; Kintziger KW; Waller JL; Diamond M; Murphy M; Kheda M; Litwin SE; Sorrentino RA
    Heart Rhythm; 2015 Dec; 12(12):2395-401. PubMed ID: 26253036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends of Cardiovascular Implantable Electronic Device Infection in 3 Decades: A Population-Based Study.
    Dai M; Cai C; Vaibhav V; Sohail MR; Hayes DL; Hodge DO; Tian Y; Asirvatham R; Cochuyt JJ; Huang C; Friedman PA; Cha YM
    JACC Clin Electrophysiol; 2019 Sep; 5(9):1071-1080. PubMed ID: 31537337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The safety, efficacy, and cost-effectiveness of gentamycin-collagen sponge in multicomponent prevention strategy of cardiac implantable electronic device infections - a single-center experience.
    Kaczmarek K; Strzelecki A; Ptaszyński P; Wranicz JK; Cygankiewicz I
    Kardiol Pol; 2021; 79(10):1079-1085. PubMed ID: 34392518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attempted salvage of infected cardiovascular implantable electronic devices: Are there clinical factors that predict success?
    Peacock JE; Stafford JM; Le K; Sohail MR; Baddour LM; Prutkin JM; Danik SB; Vikram HR; Hernandez-Meneses M; Miró JM; Blank E; Naber CK; Carrillo RG; Greenspon AJ; Tseng CH; Uslan DZ
    Pacing Clin Electrophysiol; 2018 May; 41(5):524-531. PubMed ID: 29518265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and risk factors for cardiac implantable electronic device infection in current clinical settings in a Japanese population: A 20-year single-center observational study.
    Ishiguchi H; Ishikura M; Yoshida M; Imoto K; Sonoyama K; Kawabata T; Ishihara Y; Yoshiga Y; Shimizu A; Oda T
    J Cardiol; 2020 Jul; 76(1):115-122. PubMed ID: 32037251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rate of permanent cardiac implantable electronic device infections after active fixation temporary transvenous pacing: A nationwide Danish cohort study.
    Frausing MHJP; Nielsen JC; Johansen JB; Jørgensen OD; Olsen T; Gerdes C; Kristensen J; Kronborg MB
    Heart Rhythm O2; 2022 Feb; 3(1):50-56. PubMed ID: 35243435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of healthcare claims to validate the Prevention of Arrhythmia Device Infection Trial cardiac implantable electronic device infection risk score.
    Ahmed FZ; Blomström-Lundqvist C; Bloom H; Cooper C; Ellis C; Goette A; Greenspon AJ; Love CJ; Johansen JB; Philippon F; Tarakji KG; Holbrook R; Sherfesee L; Xia Y; Seshadri S; Lexcen DR; Krahn AD
    Europace; 2021 Sep; 23(9):1446-1455. PubMed ID: 33755136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular Implantable Electronic Device Infections due to Propionibacterium Species.
    El Rafei A; Desimone DC; Sohail MR; Desimone CV; Steckelberg JM; Wilson WR; Baddour LM
    Pacing Clin Electrophysiol; 2016 Jun; 39(6):522-30. PubMed ID: 26970081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonstaphylococcal infections of cardiac implantable electronic devices.
    Viola GM; Awan LL; Darouiche RO
    Circulation; 2010 May; 121(19):2085-91. PubMed ID: 20439783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leadless pacemaker implant in patients with pre-existing infections: Results from the Micra postapproval registry.
    El-Chami MF; Johansen JB; Zaidi A; Faerestrand S; Reynolds D; Garcia-Seara J; Mansourati J; Pasquie JL; McElderry HT; Roberts PR; Soejima K; Stromberg K; Piccini JP
    J Cardiovasc Electrophysiol; 2019 Apr; 30(4):569-574. PubMed ID: 30661279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of cardiac implantable electronic device infections in the United States: A population-based cohort study.
    Rennert-May E; Chew D; Lu S; Chu A; Kuriachan V; Somayaji R
    Heart Rhythm; 2020 Jul; 17(7):1125-1131. PubMed ID: 32087358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of cardiac implantable electronic device infections: incidence and risk factors.
    Han HC; Hawkins NM; Pearman CM; Birnie DH; Krahn AD
    Europace; 2021 Jun; 23(23 Suppl 4):iv3-iv10. PubMed ID: 34051086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac implantable electronic device placement following alcohol septal ablation for hypertrophic cardiomyopathy in the United States.
    Lam MC; Naidu SS; Kolte D; Kennedy K; Feldman DN; Chu AF; Abbott JD; Gordon P; Aronow HD
    J Cardiovasc Electrophysiol; 2020 Oct; 31(10):2712-2719. PubMed ID: 32671899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variability in clinical features of early versus late cardiovascular implantable electronic device pocket infections.
    Welch M; Uslan DZ; Greenspon AJ; Sohail MR; Baddour LM; Blank E; Carrillo RG; Danik SB; Del Rio A; Hellinger W; Le KY; Miro JM; Naber C; Peacock JE; Vikram HR; Tseng CH; Prutkin JM;
    Pacing Clin Electrophysiol; 2014 Aug; 37(8):955-62. PubMed ID: 24665867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular implantable electronic device infections in left ventricular assist device recipients.
    Riaz T; Nienaber JJ; Baddour LM; Walker RC; Park SJ; Sohail MR
    Pacing Clin Electrophysiol; 2014 Feb; 37(2):225-30. PubMed ID: 23998684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of timing of transvenous lead removal on outcomes in infected cardiac implantable electronic devices.
    Lee JZ; Majmundar M; Kumar A; Thakkar S; Patel HP; Sorajja D; Valverde AM; Kalra A; Cha YM; Mulpuru SK; Asirvatham SJ; Desimone CV; Deshmukh AJ
    Heart Rhythm; 2022 May; 19(5):768-775. PubMed ID: 34968739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiology of Cardiac Implantable Electronic Device Infections.
    Hussein AA; Baghdy Y; Wazni OM; Brunner MP; Kabbach G; Shao M; Gordon S; Saliba WI; Wilkoff BL; Tarakji KG
    JACC Clin Electrophysiol; 2016 Aug; 2(4):498-505. PubMed ID: 29759872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electromagnetic interference on cardiac pacemakers and implantable cardioverter defibrillators during endoscopy as reported to the US Federal Drug Administration.
    Samuels JM; Overbey DM; Wikiel KJ; Jones TS; Robinson TN; Jones EL
    Surg Endosc; 2021 Jul; 35(7):3796-3801. PubMed ID: 32804270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac implantable electronic devices with a defibrillator component and all-cause mortality in left ventricular assist device carriers: results from the PCHF-VAD registry.
    Cikes M; Jakus N; Claggett B; Brugts JJ; Timmermans P; Pouleur AC; Rubis P; Van Craenenbroeck EM; Gaizauskas E; Grundmann S; Paolillo S; Barge-Caballero E; D'Amario D; Gkouziouta A; Planinc I; Veenis JF; Jacquet LM; Houard L; Holcman K; Gigase A; Rega F; Rucinskas K; Adamopoulos S; Agostoni P; Biocina B; Gasparovic H; Lund LH; Flammer AJ; Metra M; Milicic D; Ruschitzka F;
    Eur J Heart Fail; 2019 Sep; 21(9):1129-1141. PubMed ID: 31410955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative Antibiotic Prophylaxis Following Cardiac Implantable Electronic Device Placement.
    Kabulski GM; Northup A; Wiggins BS
    J Innov Card Rhythm Manag; 2019 Aug; 10(8):3777-3784. PubMed ID: 32477744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.